One Year. One CGM.
Introducing Eversense 365. It’s the only one year CGM, and it’s designed to minimize device frustrations so you can manage your diabetes with one less burden in your way.
Our team is here for you!
Contact us by email or by phone:
service@GetEversenseCGM.com
800-439-6016
The Eversense 365 CGM System
One year of real-time continuous glucose readings, minimal device frustrations.
* There is no glucose data generated when the transmitter is removed.
References
1. Abbott. (2024) Freestyle Libre 3 User Guide ART49385-001 Rev. A 04/24
2. Dexcom (2024) G7 User Guide AW00078-10 Rev 003 MT-00078-10
3. Senseonics. (2024) Eversense 365 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001 Rev A
4. Christiansen MP et al. (2018). A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. DIABETES TECHNOLOGY & THERAPEUTICS, 20(3):197-206.
5. Deiss, D. et al. (2020). Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: A post-market registry study. Diabetes Technology and Therapeutics, 22(1), 48–52. https://doi.org/10.1089/dia.2019.0159
Disclaimer
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
Need Help?
Speaking with our expert telehealth team is fast and easy. Email, call us, or start a live chat below.
Start Live Chat
Telehealth
How It Works
FAQs
2024
UpScript IP Holdings, LLC.
©2024 Ascensia Diabetes Care Holdings AG. All rights reserved. ©2024 Senseonics, Inc. All rights reserved.